DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Bousser MG, Amarenco P, Chamorro A. et al
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30mg/day versus aspirin 100mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Cerebrovasc Dis 2009; 27: 509-518
We do not assume any responsibility for the contents of the web pages of other providers.